Table 1 Prevalence of hepatitis C antibodies and estimated population ever-infected in a representative sample of individuals living in the state capitals of Brazil, 2005–2009

Brazil

 10 – 19

9,371

0.75 (0.53 – 0.98)†

7,565,695

56,970 (39,947 – 74,068)

 20 – 39

5,552

1.36 (1.02 – 1.71)†

13,828,140

188,478 (140,494 – 236,462)

 40 – 59

3,719

1.55 (1.09 – 2.01)†

7,941,985

122,783 (86,250 – 159,396)

 60 – 69

891

3.41 (2.03 – 4.79)†

1,916,570

65,432 (38,964 – 91,900)

North

 10 – 19

1,153

0.99 (0.36 –1.63)

860,922

8,601 (3,117 – 14,093)

 20 – 69

1,135

3.22 (2.02 – 4.41)

2,093,269

67,403 (42,472 – 92,334)

Northeast

 10 – 19

1,840

0.38 (0.10 – 0.66)

2,054,539

7,848 (2,096 – 13,601)

 20 – 69

1,850

0.97 (0.48 – 1.47)

5,358,923

52,249 (25,616 – 78,883)

Midwest

 10 – 19

1,803

0.99 (0.53 – 1.47)

866,536

8,657 (4,601 – 12,712)

 20 – 69

1,899

1.64 (1.14 – 2.13)

1,326,575

21,703 (15,110 – 28,296)

Federal District

 10 – 19

980

0.61 (0.13 – 1.09)

387,831

2,374 (524 – 4,227)

 20 – 69

1,008

1.09 (0.50 – 1.68)

1,202,183

13,116 (6,011 – 20,245)

Southeast

 10 – 19

1,794

0.90 (0.49 – 1.31)

3,295,110

29,755 (16,212 – 43,298)

 20 – 69

1,867

1.63 (1.07 – 2.18)

11,661,984

189,857 (124,783 – 254,814)

South

 10 – 19

1,801

0.51 (0.12 – 0.89)

586,270

2,978 (715 – 5,241)

 20 – 69

2,373

1.70 (1.08 – 2.32)

2,043,761

34,826 (22,175 – 47,456)